Derwent SequenceBase is the definitive web-based access point for comprehensive patent sequence searching, featuring streamlined, non-redundant versions of the ground-breaking USGENE®, GENESEQ, and GENESEQ FASTAlert databases.
Pharmaceutical firms, biotech companies, academia and law firms rely on the Derwent SequenceBase portal, as their solution for all their Intellectual Property (IP) sequence searching needs, including patentability, freedom-to-operate, patent infringement, validity, and business intelligence.
Key benefits include:
The amount of legal and scientific data recorded in patent sequence datasets has grown exponentially. Scientists and legal professionals carrying out essential IP research are seeking the best and simplest way to discover IP sequence information across disparate resources.
IP specialists use Derwent SequenceBase, the online IP research solution with easy-to-use, readily accessible content set of solutions for data and the technology to manipulate data supporting both chemical (DCPI/DI) and biologic patent activity prominent in the life sciences market.
Licensing and business development professionals
Reducing the risk of missing relevant patents when searching for genetically engineered sequences
Watch this webinar to learn how new biological therapeutic approaches such as CAR-T cell therapies present challenges for patent searchers. We will illustrate how new tools, such as GENESEQ on SequenceBase and Derwent Innovation, can be used to reduce the margin for error during the patent search process, greatly increasing the speed and accuracy of your search for engineered sequences and the assessment of freedom to operate and actual infringement risk.
Talk to us today